Autifony

News

Introducing the Sunday Times Tech 100: Life sciences part 2

In our second of three reports on the 2026 Sunday Times Tech 100, we focus on the first nine of 18 life sciences companies in the hardware category.

News

Autifony swings $770.5m deal with Jazz for CNS drugs

UK biotech Autifony has signed an exclusive licensing deal with Jazz Pharmaceuticals, giving the Ireland-headquartered drugmaker global rights to a pair of ion channel tar

News

Boehringer collaborates with Autifony on schizophrenia drug

Deal could be worth 627.5 million euros

Introducing the Sunday Times Tech 100: Life sciences part 2

Autifony swings $770.5m deal with Jazz for CNS drugs

Boehringer collaborates with Autifony on schizophrenia drug

Ex-BioNTech execs launch 'AI-native' cancer company

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks